Oral hormone pregnancy tests and the risks of congenital malformations: A systematic review and meta-analysis
<strong>Background</strong>: Oral hormone pregnancy tests (HPTs), such as Primodos, containing ethinylestradiol and high doses of norethisterone, were given to over a million women from 1958 to 1978, when Primodos was withdrawn from the market because of concerns about possible teratogen...
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Journal article |
| 出版: |
F1000Research
2018
|